Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Evan Lamb"'
Autor:
Kai Wu, Ian N. Moore, Bridget Bart, John-Paul Todd, Elham Bayat Mokhtari, Gabriela S. Alvarado, Swagata Kar, Jaclyn Wear, Manjari Sriparna, Kathryn E. Foulds, Matthew Gagne, Mario Roederer, Kizzmekia S. Corbett, Seyhan Boyoglu-Barnum, Darin K. Edwards, Barbara J. Flynn, Katelyn Steingrebe, Adrian B. McDermott, Samantha J. Provost, Angela Choi, Shayne F. Andrew, Eli Boritz, Sayda Elbashir, Zackery Flinchbaugh, Timothy S. Johnston, Martha Nason, Sarah O’ Connell, Anthony Cook, Bianca M. Nagata, Mahnaz Minai, Prakriti Mudvari, Mark G. Lewis, Andrew Pekosz, Amy R. Henry, Farida Laboune, Dillon R. Flebbe, Becky Chang, Alex Van Ry, Nancy J. Sullivan, Juan I. Moliva, Saule T. Nurmukhambetova, Laurent Pessaint, Lilin Lai, Matthew A. Koch, Barney S. Graham, Hanne Leth Andersen, Maciel Porto, Kevin W. Bock, Daniel C. Douek, Anne P. Werner, Mehul S. Suthar, Evan Lamb, Alan Dodson, Andrea Carfi, Robert A. Seder
Publikováno v:
Nature Immunology. 22:1306-1315
B.1.351 is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant most resistant to antibody neutralization. We demonstrate how the dose and number of immunizations influence protection. Nonhuman primates received two doses of 30 or
Autor:
Ian N. Moore, Seyhan Boyoglu-Barnum, Swagata Kar, Bianca M. Nagata, Shayne F. Andrew, Joseph R. Francica, John R. Mascola, Shruti N. Shah, Darin K. Edwards, Samantha J. Provost, Barney S. Graham, John Paul Todd, Venkata Viswanadh Edara, Eun Sung Yang, Daniel Valentin, Katelyn Steingrebe, David C. Montefiori, Andrea Carfi, Maciel Porto, Hanne Leth Andersen, Robert A. Seder, Kizzmekia S. Corbett, Wei Shi, Jack Greenhouse, Mark G. Lewis, Evan Lamb, Adrian B. McDermott, Daniel C. Douek, Serge Zouantcha, Kathryn E. Foulds, Nancy J. Sullivan, Mahnaz Minai, Kevin W. Bock, Britta Flach, Lilin Lai, Katharine Floyd, Angela Choi, Charlene McDanal, Jonathan Fintzi, Alan Dodson, Matthew A. Koch, Mario Roederer, Amy T. Noe, Juan I. Moliva, Saule T. Nurmukhambetova, Mitzi M. Donaldson, Laurent Pessaint, Timothy S. Johnston, Andrew Faudree, Anne P. Werner, Mehul S. Suthar, Barbara J. Flynn, Kai Wu, Anthony L. Cook, Sarah O’Connell, Gabriela S. Alvarado, Lingshu Wang, Yi Zhang, Martha Nason, Dillon R. Flebbe, Matthew Gagne, Olubukola M. Abiona, Renee van de Wetering, Kwanyee Leung
Publikováno v:
Science
Immune correlates of protection can be used as surrogate endpoints for vaccine efficacy. The nonhuman primate (NHP) model of SARS-CoV-2 infection replicates key features of human infection and may be used to define immune correlates of protection fol
Autor:
Daniel C. Douek, Rachel L. Davis, Alex Van Ry, Timothy S. Johnston, Stephen D. Schmidt, Adrian B. McDermott, John R. Mascola, Yi Zhang, Anne P. Werner, Lilin Lai, Evan Lamb, Sarah O’ Connell, Kevin W. Bock, John-Paul Todd, Misook Choe, Amy R. Henry, Wei Shi, Alan Dodson, Danielle A. Wagner, Matthew A. Koch, Barney S. Graham, Aurélie Ploquin, Mehul S. Suthar, Farida Laboune, Chaim A. Schramm, Mitzi M. Donaldson, Samantha J. Provost, John Misasi, Christopher Stringham, Bianca M. Nagata, Hanne Leth Andersen, Ian N. Moore, Kizzmekia S. Corbett, Andrea Carfi, Robert A. Seder, Sandeep Narpala, Seyhan Boyoglu-Barnum, Mark G. Lewis, Josue Marquez, Sijy O'Dell, Nancy J. Sullivan, Lingshu Wang, Juan I. Moliva, Saule T. Nurmukhambetova, Courtney Tucker, Zackery Flinchbaugh, Laurent Pessaint, Shayne F. Andrew, Mahnaz Minai, Eli Boritz, Barbara J. Flynn, Andrew Pekosz, Dillon R. Flebbe, Daniel Valentin, Darin K. Edwards, Matthew Gagne, Angela Choi, Manjari Sriparna, Kathryn E. Foulds, Martha Nason, Anthony L. Cook, Gabriela S. Alvarado, Kai Wu, Nicole A. Doria-Rose, Mario Roederer
Publikováno v:
bioRxiv
Neutralizing antibody responses gradually wane after vaccination with mRNA-1273 against several variants of concern (VOC), and additional boost vaccinations may be required to sustain immunity and protection. Here, we evaluated the immune responses i
Autor:
Anthony L. Cook, Hanne Leth Andersen, John-Paul Todd, Sophie Ruiz, Katharine Floyd, Tongqing Zhou, Evan Lamb, Shayne F. Andrew, Britta Flach, Sally Shin, Timothy S. Johnston, Catherine C. Berry, Sarah O’Connell, Nancy J. Sullivan, Joseph R. Francica, Stephanie Fischinger, Alida Tylor, Dapeng Li, Kathryn E. Foulds, Daniel C. Douek, Robert A. Seder, Alex Lee Zhu, Ian N. Moore, Rachel L. Davis, Roman Chicz, Mark G. Lewis, Courtney Tucker, Alex Van Ry, Elizabeth McCarthy, Barney S. Graham, Marguerite Koutsoukos, Robbert van der Most, I.-Ting Teng, Amy T. Noe, Cindy Gutzeit, Matthew Gagne, Mitzi M. Donaldson, Alan Dodson, Tong-Ming Fu, Saule T. Nurmukhambetova, Laurent Pessaint, Venkata Viswanadh Edara, Adrian B. McDermott, Renee van de Wetering, Kizzmekia S. Corbett, Peter D. Kwong, Danilo Casimiro, Timothy Tibbitts, Barbara J. Flynn, Seyhan Boyoglu-Barnum, Valerie Lecouturier, Matthew J. Gorman, Anne P. Werner, Dillon R. Flebbe, Mehul S. Suthar, Mario Roederer, Lilin Lai, Caroline Atyeo, Barton F. Haynes, Galit Alter
Publikováno v:
Science Translational Medicine. 13
Adjuvanted soluble protein vaccines have been used extensively in humans for protection against various viral infections based on their robust induction of antibody responses. Here, soluble prefusion-stabilized spike protein trimers (preS dTM) from s
Autor:
Kizzmekia S. Corbett, Anne P. Werner, Sarah O’ Connell, Matthew Gagne, Lilin Lai, Juan I. Moliva, Barbara Flynn, Angela Choi, Matthew Koch, Kathryn E. Foulds, Shayne F. Andrew, Dillon R. Flebbe, Evan Lamb, Saule T. Nurmukhambetova, Samantha J. Provost, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Alex Van Ry, Zackery Flinchbaugh, Timothy S. Johnston, Elham Bayat Mokhtari, Prakriti Mudvari, Amy R. Henry, Farida Laboune, Becky Chang, Maciel Porto, Jaclyn Wear, Gabriela S. Alvarado, Seyhan Boyoglu-Barnum, John-Paul M. Todd, Bridget Bart, Anthony Cook, Alan Dodson, Laurent Pessaint, Katelyn Steingrebe, Sayda Elbashir, Hanne Andersen, Kai Wu, Darin K. Edwards, Swagata Kar, Mark G. Lewis, Eli Bortiz, Ian N. Moore, Andrea Carfi, Mehul S. Suthar, Adrian McDermott, Mario Roederer, Martha C. Nason, Nancy J. Sullivan, Daniel C. Douek, Barney S. Graham, Robert A. Seder
Publikováno v:
bioRxiv
BackgroundVaccine efficacy against the B.1.351 variant following mRNA-1273 vaccination in humans has not been determined. Nonhuman primates (NHP) are a useful model for demonstrating whether mRNA-1273 mediates protection against B.1.351.MethodsNonhum
Autor:
Kizzmekia S. Corbett, Martha C. Nason, Britta Flach, Matthew Gagne, Sarah O’ Connell, Timothy S. Johnston, Shruti N. Shah, Venkata Viswanadh Edara, Katharine Floyd, Lilin Lai, Charlene McDanal, Joseph R. Francica, Barbara Flynn, Kai Wu, Angela Choi, Matthew Koch, Olubukola M. Abiona, Anne P. Werner, Gabriela S. Alvarado, Shayne F. Andrew, Mitzi M. Donaldson, Jonathan Fintzi, Dillon R. Flebbe, Evan Lamb, Amy T. Noe, Saule T. Nurmukhambetova, Samantha J. Provost, Anthony Cook, Alan Dodson, Andrew Faudree, Jack Greenhouse, Swagata Kar, Laurent Pessaint, Maciel Porto, Katelyn Steingrebe, Daniel Valentin, Serge Zouantcha, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Juan I. Moliva, Renee van de Wetering, Seyhan Boyoglu-Barnum, Kwanyee Leung, Wei Shi, Eun Sung Yang, Yi Zhang, John-Paul M. Todd, Lingshu Wang, Hanne Andersen, Kathryn E. Foulds, Darin K. Edwards, John R. Mascola, Ian N. Moore, Mark G. Lewis, Andrea Carfi, David Montefiori, Mehul S. Suthar, Adrian McDermott, Nancy J. Sullivan, Mario Roederer, Daniel C. Douek, Barney S. Graham, Robert A. Seder
Publikováno v:
bioRxiv
Immune correlates of protection can be used as surrogate endpoints for vaccine efficacy. The nonhuman primate (NHP) model of SARS-CoV-2 infection replicates key features of human infection and may be used to define immune correlates of protection fol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a2c90ec45ef1373e88339143a1b79f
https://doi.org/10.1101/2021.04.20.440647
https://doi.org/10.1101/2021.04.20.440647
Publikováno v:
Mol Microbiol
Motile bacteria are proficient at finding optimal environments for colonization. Often, they use chemotaxis to sense nutrient availability and dangerous concentrations of toxic chemicals. For many bacteria, the repertoire of chemoreceptors is large,
Autor:
Alex Van Ry, Mark G. Lewis, Alida Tylor, Amy T. Noe, Kathryn E. Foulds, I-Ting Teng, Mitzi M. Donaldson, Peter D. Kwong, Evan Lamb, Britta Flach, Barney S. Graham, Matthew Gagne, Timothy S. Johnston, Robert A. Seder, Venkata Viswanadh Edara, Barbara J. Flynn, Cindy Gutzeit, Hanne Leth Andersen, Joseph R. Francica, Lilin Lai, Tong-Ming Fu, Alex Lee Zhu, Roman Chicz, Alan Dodson, Danilo Casimiro, Sally Shin, Rachel L. Davis, Shayne F. Andrew, Saule T. Nurmukhambetova, Elizabeth McCarthy, Kizzmekia S. Corbett, Dillon R. Flebbe, Tongqing Zhou, Laurent Pessaint, Stephanie Fischinger, Courtney Tucker, Matthew J. Gorman, Nancy J. Sullivan, Anthony L. Cook, Dapeng Li, Adrian B. McDermott, Katharine Floyd, Anne P. Werner, Caroline Atyeo, Barton F. Haynes, Mehul S. Suthar, Galit Alter, Ian N. Morre, Daniel C. Douek, Timothy Tibbitts, John-Paul Todd, Marguerite Koutsoukos, Robbert van der Most
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Adjuvanted soluble protein vaccines have been used extensively in humans for protection against various viral infections based on their robust induction of antibody responses. Here, soluble prefusion-stabilized spike trimers (preS dTM) from the sever
Autor:
Ingelise J. Gordon, Mark G. Lewis, Gabriela S. Alvarado, Ralph S. Baric, Martin R. Gaudinski, Laura Novik, Kwanyee Leung, Jack Greenhouse, Tammy Putman-Taylor, Katelyn Steingrebe, Seyhan Boyoglu-Barnum, Kathryn E. Foulds, Tracey-Ann Campbell, Tongqing Zhou, Wei Shi, I-Ting Teng, Peter D. Kwong, Juan I. Moliva, Laurent Pessaint, Christina Yap, Mahnaz Minai, Olubukola M. Abiona, Nancy J. Sullivan, Nadesh N Nji, Kaitlyn M. Morabito, Amarendra Pegu, Stephen D. Schmidt, Julie E. Ledgerwood, Sunny Himansu, Barbara J. Flynn, Shanai Browne, Anne P. Werner, Darin K. Edwards, Eun Sung Yang, Kevin W. Bock, Joseph R. Francica, Yi Zhang, Dillon R. Flebbe, Kizzmekia S. Corbett, Nicole A. Doria-Rose, Ian N. Moore, Andrea Carfi, Amanda Strasbaugh, Mario Roederer, Guillaume Stewart-Jones, Emily Phung, Robert A. Seder, Tracy J. Ruckwardt, Adrian B. McDermott, Anthony Cook, Sarah O’Connell, Alicia T. Widge, Wing-Pui Kong, Mark K. Louder, Martha Nason, Bob C. Lin, David R. Martinez, Alex Van Ry, Alan Dodson, Evan Lamb, Britta Flach, Bianca M. Nagata, Rebecca J. Loomis, John R. Mascola, Barney S. Graham, John-Paul Todd, Sijy O'Dell, Lauren A. Chang, Naomi Douek, Lingshu Wang, Rebecca A. Gillespie, Hanne Leth Andersen, Amy T. Noe, Mitzi M. Donaldson
Publikováno v:
New England Journal of Medicine
The New England Journal of Medicine
The New England Journal of Medicine
Background: Vaccines to prevent coronavirus disease 2019 (Covid-19) are urgently needed. The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines on viral replication in both upper and lower airways is important to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1beae7dcc7af2b55333337512c240b
Publikováno v:
The FASEB Journal. 29
The objective was to evaluate gut microbiome in relation to recent aspartame and Acesulfame-K artificial sweetener consumption. Thirty-one adults completed a four-day food record and provided a fecal sample on the fifth day. Fecal samples were analyz